vs
Side-by-side financial comparison of FGI Industries Ltd. (FGI) and Pulmonx Corp (LUNG). Click either name above to swap in a different company.
FGI Industries Ltd. is the larger business by last-quarter revenue ($30.5M vs $20.6M, roughly 1.5× Pulmonx Corp). FGI Industries Ltd. runs the higher net margin — -8.6% vs -66.3%, a 57.7% gap on every dollar of revenue. On growth, Pulmonx Corp posted the faster year-over-year revenue change (-8.7% vs -14.4%). Over the past eight quarters, FGI Industries Ltd.'s revenue compounded faster (-0.5% CAGR vs -0.5%).
FGI Industries Ltd is a global designer, manufacturer and distributor of kitchen and bath products, home organization solutions, and home improvement goods. It serves major retail chains, home specialty stores and e-commerce platforms across North America, Europe and the Asia-Pacific region.
Pulmonx Corp is a global medical tech firm focused on interventional pulmonology solutions. It develops minimally invasive endobronchial valves to treat severe COPD and emphysema, with products sold across North America, Europe, and Asia-Pacific for patients with advanced lung conditions.
FGI vs LUNG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $30.5M | $20.6M |
| Net Profit | $-2.6M | $-13.7M |
| Gross Margin | 26.7% | 77.9% |
| Operating Margin | -2.2% | -40.9% |
| Net Margin | -8.6% | -66.3% |
| Revenue YoY | -14.4% | -8.7% |
| Net Profit YoY | -553.1% | 5.5% |
| EPS (diluted) | $-1.63 | $-0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $20.6M | ||
| Q4 25 | $30.5M | $22.6M | ||
| Q3 25 | $35.8M | $21.5M | ||
| Q2 25 | $31.0M | $23.9M | ||
| Q1 25 | $33.2M | $22.5M | ||
| Q4 24 | $35.6M | $23.8M | ||
| Q3 24 | $36.1M | $20.4M | ||
| Q2 24 | $29.4M | $20.8M |
| Q1 26 | — | $-13.7M | ||
| Q4 25 | $-2.6M | $-10.4M | ||
| Q3 25 | $-1.7M | $-14.0M | ||
| Q2 25 | $-1.2M | $-15.2M | ||
| Q1 25 | $-629.1K | $-14.4M | ||
| Q4 24 | $-402.3K | $-13.2M | ||
| Q3 24 | $-550.1K | $-14.1M | ||
| Q2 24 | $163.6K | $-15.3M |
| Q1 26 | — | 77.9% | ||
| Q4 25 | 26.7% | 77.6% | ||
| Q3 25 | 26.5% | 74.7% | ||
| Q2 25 | 28.1% | 72.1% | ||
| Q1 25 | 26.8% | 72.5% | ||
| Q4 24 | 24.6% | 74.0% | ||
| Q3 24 | 25.8% | 73.7% | ||
| Q2 24 | 30.5% | 73.7% |
| Q1 26 | — | -40.9% | ||
| Q4 25 | -2.2% | -43.8% | ||
| Q3 25 | 1.0% | -66.9% | ||
| Q2 25 | -2.7% | -62.0% | ||
| Q1 25 | -3.9% | -64.6% | ||
| Q4 24 | -3.5% | -56.5% | ||
| Q3 24 | -0.2% | -69.3% | ||
| Q2 24 | -1.5% | -75.2% |
| Q1 26 | — | -66.3% | ||
| Q4 25 | -8.6% | -46.1% | ||
| Q3 25 | -4.6% | -64.9% | ||
| Q2 25 | -4.0% | -63.6% | ||
| Q1 25 | -1.9% | -64.1% | ||
| Q4 24 | -1.1% | -55.4% | ||
| Q3 24 | -1.5% | -69.4% | ||
| Q2 24 | 0.6% | -73.7% |
| Q1 26 | — | $-0.33 | ||
| Q4 25 | $-1.63 | $-0.25 | ||
| Q3 25 | $-0.86 | $-0.34 | ||
| Q2 25 | $-0.64 | $-0.38 | ||
| Q1 25 | $-0.07 | $-0.36 | ||
| Q4 24 | $-0.38 | $-0.33 | ||
| Q3 24 | $-0.29 | $-0.36 | ||
| Q2 24 | $0.08 | $-0.39 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.9M | $61.6M |
| Total DebtLower is stronger | — | $37.3M |
| Stockholders' EquityBook value | $17.3M | $45.8M |
| Total Assets | $69.5M | $120.0M |
| Debt / EquityLower = less leverage | — | 0.82× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $61.6M | ||
| Q4 25 | $1.9M | $69.8M | ||
| Q3 25 | $1.9M | $76.5M | ||
| Q2 25 | $2.5M | $75.5M | ||
| Q1 25 | $1.2M | $74.6M | ||
| Q4 24 | $4.6M | $70.9M | ||
| Q3 24 | $3.0M | $63.3M | ||
| Q2 24 | $1.3M | $63.5M |
| Q1 26 | — | $37.3M | ||
| Q4 25 | — | $37.1M | ||
| Q3 25 | — | $37.1M | ||
| Q2 25 | — | $37.1M | ||
| Q1 25 | — | $37.2M | ||
| Q4 24 | — | $37.2M | ||
| Q3 24 | — | $37.2M | ||
| Q2 24 | — | $37.2M |
| Q1 26 | — | $45.8M | ||
| Q4 25 | $17.3M | $54.1M | ||
| Q3 25 | $19.7M | $60.0M | ||
| Q2 25 | $21.3M | $69.1M | ||
| Q1 25 | $21.8M | $77.7M | ||
| Q4 24 | $22.3M | $85.8M | ||
| Q3 24 | $23.5M | $93.9M | ||
| Q2 24 | $23.8M | $101.2M |
| Q1 26 | — | $120.0M | ||
| Q4 25 | $69.5M | $129.3M | ||
| Q3 25 | $73.0M | $138.3M | ||
| Q2 25 | $71.7M | $147.2M | ||
| Q1 25 | $68.5M | $150.7M | ||
| Q4 24 | $75.5M | $162.8M | ||
| Q3 24 | $74.7M | $167.4M | ||
| Q2 24 | $69.9M | $172.6M |
| Q1 26 | — | 0.82× | ||
| Q4 25 | — | 0.69× | ||
| Q3 25 | — | 0.62× | ||
| Q2 25 | — | 0.54× | ||
| Q1 25 | — | 0.48× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.40× | ||
| Q2 24 | — | 0.37× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.3M | — |
| Free Cash FlowOCF − Capex | $2.3M | — |
| FCF MarginFCF / Revenue | 7.5% | — |
| Capex IntensityCapex / Revenue | 0.2% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-212.5K | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $2.3M | $-7.1M | ||
| Q3 25 | $-1.9M | $-8.2M | ||
| Q2 25 | $7.6M | $-3.9M | ||
| Q1 25 | $-7.4M | $-13.2M | ||
| Q4 24 | $617.4K | $-6.7M | ||
| Q3 24 | $-915.0K | $-7.2M | ||
| Q2 24 | $862.1K | $-5.8M |
| Q1 26 | — | — | ||
| Q4 25 | $2.3M | $-7.1M | ||
| Q3 25 | $-2.1M | $-8.3M | ||
| Q2 25 | $7.4M | $-4.0M | ||
| Q1 25 | $-7.7M | $-13.5M | ||
| Q4 24 | $-214.1K | $-6.8M | ||
| Q3 24 | $-1.1M | $-7.7M | ||
| Q2 24 | $281.5K | $-6.2M |
| Q1 26 | — | — | ||
| Q4 25 | 7.5% | -31.4% | ||
| Q3 25 | -5.9% | -38.4% | ||
| Q2 25 | 23.8% | -16.6% | ||
| Q1 25 | -23.3% | -60.0% | ||
| Q4 24 | -0.6% | -28.8% | ||
| Q3 24 | -3.0% | -37.6% | ||
| Q2 24 | 1.0% | -30.0% |
| Q1 26 | — | — | ||
| Q4 25 | 0.2% | 0.1% | ||
| Q3 25 | 0.7% | 0.4% | ||
| Q2 25 | 0.7% | 0.2% | ||
| Q1 25 | 1.1% | 1.3% | ||
| Q4 24 | 2.3% | 0.5% | ||
| Q3 24 | 0.5% | 2.0% | ||
| Q2 24 | 2.0% | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 5.27× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FGI
| Sanitaryware | $19.1M | 63% |
| Shower System | $5.8M | 19% |
| Kitchen And Bath Other | $3.3M | 11% |
| Bath Furniture Products | $2.3M | 7% |
LUNG
Segment breakdown not available.
